Upcoming research by the Global Strategy Lab’s AMR Policy Accelerator in collaboration with the World Health Organization (WHO) shows findings on gender-specific risks associated with antimicrobial resistance (AMR). A recent article by the Financial Times highlights key findings from this analysis. For more detailed insights, you can read the full article on the financial times website here.
The study showed that women, especially in low-resource areas, face higher risks of drug resistant infections due to biological, cultural, social, and economic factors. Their findings, based on 130, studies will be formally published on July 11th during a WHO webinar on gender inequalities and national action pans on antimicrobial resistance.
Previous